Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BERNOULLI VENTILATOR MANAGEMENT SYSTEM

K-Number: K011861 · 2001-11-06

ApplicantCardiopulmonary Corp.
Decision Date2001-11-06
Product CodeMOD
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

BERNOULLI VENTILATOR MANAGEMENT SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Cardiopulmonary Corp.. It received FDA 510(k) clearance on 2001-11-06 under 510(k) number K011861. The device is classified under product code MOD. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BERNOULLI VENTILATOR MANAGEMENT SYSTEM?

BERNOULLI VENTILATOR MANAGEMENT SYSTEM is a medical device that received FDA 510(k) clearance on 2001-11-06. The listed applicant is Cardiopulmonary Corp.. The 510(k) number is K011861.

When did BERNOULLI VENTILATOR MANAGEMENT SYSTEM receive FDA 510(k) clearance?

BERNOULLI VENTILATOR MANAGEMENT SYSTEM received FDA 510(k) clearance on 2001-11-06, under 510(k) number K011861.

Who is the listed applicant for BERNOULLI VENTILATOR MANAGEMENT SYSTEM?

The FDA 510(k) record lists Cardiopulmonary Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BERNOULLI VENTILATOR MANAGEMENT SYSTEM?

The FDA product code for BERNOULLI VENTILATOR MANAGEMENT SYSTEM is MOD.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Cardiopulmonary Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K130208BERNOULLI ENTERPRISE SOFTWAREK091461BERNOULLI MANAGEMENT SYSTEM, OXINET III AND LIFEGARD VUEK061932BERNOULLI MANAGEMENT SYSTEM (MS) SOFTWAREK051283MODIFICATION TO BERNOULLI VENTILATOR MANAGEMENT SYSTEM SOFTWAREK020018MODIFICATION TO BERNOULLI VENTILATOR MANAGEMENT SYSTEM SOFTWAREK990429MODIFICATION OF VENTURI VENTILATOR

View all 9 devices →

Related Devices (Code: MOD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261360EasyCare Tx 2Resmed CorpK253807Valence InVent Xtend™ (CVG-4101-VXA)Convergence Medical Sciences , Ltd.K260051CorVision® (91-205-Z0014)CorVent® Medical, Inc.K242485EveryWareBreas Medical ABK161411Care Cycle Connect ApplicationRespironics, Inc.K091461BERNOULLI MANAGEMENT SYSTEM, OXINET III AND LIFEGARD VUECardiopulmonary Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑